MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-16885

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    Perhaps @whytee you are confused and you mean the Type A Remestemcel-L meeting announcement on 21 September where the company make specific reference to the FDA meeting being productive ?


    .... not an Annual Report though is it and of course certainly not in reference to CHF


    Enjoy your day ....


    upload_2023-10-2_11-37-43.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.